seed
Stage
1
Investors
About
GILUPI GmbH develops medical devices and workflows for the in vivo capture and analysis of circulating tumor cells from patients' blood to support cancer diagnostics and monitoring.
Explore GILUPI GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.